
Margherita Ambrosini/LinkedIn
Apr 10, 2025, 11:25
Margherita Ambrosini: Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
Margherita Ambrosini, Medical Doctor, Oncology Clinical and Research Fellow at the Fondazione IRCCS National Cancer Institute in Milan, shared a post on LinkedIn:
“In this review, we delve into the key features of MSI-H/dMMR cancers, shedding light on current diagnostic challenges and the impact of immune checkpoint inhibitors across both advanced and early-stage disease.
Have a look.”
“Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers”
Authors: Margherita Ambrosini, Paolo Manca, Vincenzo Nasca, Carolina Sciortino, Filippo Ghelardi, Jenny F. Seligmann, Julien Taieb, Filippo Pietrantonio
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 17:17
Apr 15, 2025, 17:01
Apr 15, 2025, 16:16
Apr 15, 2025, 15:50
Apr 15, 2025, 15:31
Apr 15, 2025, 15:26